BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33122009)

  • 1. Sodium bicarbonate gels: a new promising strategy for the treatment of vulvovaginal candidosis.
    Tomás M; Rolo J; Gaspar C; Palmeira-de-Oliveira A; Simões S; Katz DF; Martinez-de-Oliveira J; Palmeira-de-Oliveira R
    Eur J Pharm Sci; 2021 Feb; 157():105621. PubMed ID: 33122009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Difference Between the Profiles Presented by Yeasts that Colonize the Vaginal Mucosa or Cause Primary or Recurrent Candidiasis.
    Moreira D; Ruiz LS; Leite-Jr DP; Auler ME; Ramos RTB; Costa VT; Lara BR; Gasparetto A; Gandra RF; Melhem MSC; Paula CR
    Mycopathologia; 2021 Jun; 186(3):411-421. PubMed ID: 34120275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).
    Mendling W; Brasch J; Cornely OA; Effendy I; Friese K; Ginter-Hanselmayer G; Hof H; Mayser P; Mylonas I; Ruhnke M; Schaller M; Weissenbacher ER
    Mycoses; 2015 Mar; 58 Suppl 1():1-15. PubMed ID: 25711406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates.
    Waikhom SD; Afeke I; Kwawu GS; Mbroh HK; Osei GY; Louis B; Deku JG; Kasu ES; Mensah P; Agede CY; Dodoo C; Asiamah EA; Tampuori J; Korbuvi J; Opintan JA
    BMC Pregnancy Childbirth; 2020 May; 20(1):266. PubMed ID: 32375724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifungal effect of hydroethanolic extract of Fridericia chica (Bonpl.) L. G. Lohmann leaves and its therapeutic use in a vulvovaginal candidosis model.
    Lima WG; Araújo MGF; Brito JCM; Castilho RO; Cardoso VN; Fernandes SOA
    J Mycol Med; 2022 Aug; 32(3):101255. PubMed ID: 35219909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of overtime phenotypic variation of yeasts in chronic vulvovaginal candidosis cases.
    Faria-Gonçalves P; Gaspar C; Oliveira AS; Palmeira-de-Oliveira R; Gonçalves T; Martinez-de-Oliveira J; Palmeira-de-Oliveira A; Rolo J
    Med Mycol; 2021 Dec; 59(12):1166-1173. PubMed ID: 34427667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.
    Ray D; Goswami R; Banerjee U; Dadhwal V; Goswami D; Mandal P; Sreenivas V; Kochupillai N
    Diabetes Care; 2007 Feb; 30(2):312-7. PubMed ID: 17259500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of the novel echinocandin CD101 at pH 7 and 4 against Candida spp. isolates from patients with vulvovaginal candidiasis.
    Boikov DA; Locke JB; James KD; Bartizal K; Sobel JD
    J Antimicrob Chemother; 2017 May; 72(5):1355-1358. PubMed ID: 28158577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and in vivo evaluation of chitosan-gel containing Mitracarpus frigidus methanolic extract for vulvovaginal candidiasis treatment.
    Campos LM; de Oliveira Lemos AS; da Cruz LF; de Freitas Araújo MG; de Mello Botti GCR; Júnior JLR; Rocha VN; Denadai ÂML; da Silva TP; Tavares GD; Scio E; Fabri RL; Pinto PF
    Biomed Pharmacother; 2020 Oct; 130():110609. PubMed ID: 34321177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guideline vulvovaginal candidosis (2010) of the German Society for Gynecology and Obstetrics, the Working Group for Infections and Infectimmunology in Gynecology and Obstetrics, the German Society of Dermatology, the Board of German Dermatologists and the German Speaking Mycological Society.
    Mendling W; Brasch J; ; ; ;
    Mycoses; 2012 Jul; 55 Suppl 3():1-13. PubMed ID: 22519657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p-Coumaric acid loaded into liquid crystalline systems as a novel strategy to the treatment of vulvovaginal candidiasis.
    Ferreira PS; Victorelli FD; Rodero CF; Fortunato GC; Araújo VHS; Fonseca-Santos B; Bauab TM; Van Dijck P; Chorilli M
    Int J Pharm; 2021 Jun; 603():120658. PubMed ID: 33964336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin-Loaded Liquid Crystalline Systems for Controlled Drug Release and Improved Treatment of Vulvovaginal Candidiasis.
    Rodero CF; Fioramonti Calixto GM; Cristina Dos Santos K; Sato MR; Aparecido Dos Santos Ramos M; Miró MS; Rodríguez E; Vigezzi C; Bauab TM; Sotomayor CE; Chorilli M
    Mol Pharm; 2018 Oct; 15(10):4491-4504. PubMed ID: 30184431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaginal homeostasis features of Vulvovaginal Candidiasis through vaginal metabolic profiling.
    Chen X; Wang J; Chen J; Wang G; Zhang R; Qiu J
    Med Mycol; 2023 Aug; 61(8):. PubMed ID: 37573133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combined single-day treatment in acute vulvovaginal candidosis].
    Kovachev S; Nacheva A; Vacheva-Dobrevska R; Vasilev N
    Akush Ginekol (Sofiia); 2009; 48(6):18-23. PubMed ID: 20225492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanolipid Gel of an Antimycotic Drug for Treating Vulvovaginal Candidiasis-Development and Evaluation.
    Takalkar D; Desai N
    AAPS PharmSciTech; 2018 Apr; 19(3):1297-1307. PubMed ID: 29340981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative investigation of azole susceptibility in Candida isolates from vulvovaginal candidiasis and recurrent vulvovaginal candidiasis patients in Ghana.
    Adjapong G; Hale M; Garrill A
    Med Mycol; 2017 Aug; 55(6):686-689. PubMed ID: 27838642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics of vulvovaginal candidiasis and antifungal susceptibilities of Candida species isolates among patients in southern China from 2003 to 2006.
    Fan SR; Liu XP; Li JW
    J Obstet Gynaecol Res; 2008 Aug; 34(4):561-6. PubMed ID: 18937710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and mycological efficacy of single-day oral treatment with itraconazole (400 mg) in acute vulvovaginal candidosis.
    Urünsak M; Ilkit M; Evrüke C; Urünsak I
    Mycoses; 2004 Oct; 47(9-10):422-7. PubMed ID: 15504127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of mucoadhesive thermoresponsive systems containing propolis for the treatment of vulvovaginal candidiasis.
    Pereira RR; Ribeiro Godoy JS; Stivalet Svidzinski TI; Bruschi ML
    J Pharm Sci; 2013 Apr; 102(4):1222-34. PubMed ID: 23334938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.